Shares in Value Logo
Product Review Img Vertical

Date : 12/02/2021

Learn why AVITA Medical (ASX:AVH) is down by 12% today

AVITA Medical is a regenerative medicine company that is into developing and commercialising a technology platform for skin restoration for multiple unmet medical needs. Avita is also listed on the NASDAQ and they reported its financial results for the 2nd quarter of FY2021. Avita is a $3.8 billion market cap company that has had a torrid time during the pandemic, at least as far as the share price is concerned. The financial result for the second quarter that was reported has sent Avita Medical share price tumbling by over 12% due to a couple of concerns even though the firm reported an uptick in revenues. Revenues increased by 57% compared to the previous corresponding period and it now stands at $5.1 million. Operating expenses decreased by $3 million during the quarter and it is now $10.4 million. Avita also holds close to $60 million in cash on its balance sheet. The dip in share price is largely due to the firm now being confident enough to issue a full year guidance to the market. Avita Medical reported a net loss of $5.6 million during the quarter and the Covid 19 impact looks like it will have an extended impact on Avita Medical.

The AVITA Medical share price traded at A$6.160, down by 12.126% on 12 February 2021 (at AEDT 1:41 PM). This is probably one for investors to stay away from for the time being at least, however there are quite a few top ASX healthcare stocks that should catch the eye of investors looking for exposure to the sector.

Looking for Growth Stocks?

Growth stocks are potentially one of the hardest to pick as there are a lot of factors that need to be considered – from industry tailwinds to financial health of the individual stocks, and a lot of little things in between them. Shares in Value research team have picked their top 3 ASX stocks to buy in 2021. Click here to download the report for free.


Are You Looking To Buy The Best Stocks In 2024?

Stay on top of upcoming market trends! Whether you are an SMSF investor or a young investor with your portfolio, we cover a wide range of stocks across all sectors, including mining, financials, industrials, real estate, technology, health and biotech, etc. It will give you an edge to invest and trade ASX listed stocks across large, mid and small caps with an advantage.

Get stock tips with our Market Experts. We help self-directed investors and self-managed super funds (SMSF) make smarter investment decisions and get better returns. Fill in your details and download your free Report instantly for Top 3 Dividend Stocks to buy in 2024!


Top 5 ASX Stocks
to Buy for Capital Growth in 2024

Shares In Value - Top 5 ASX Stocks to Buy - Cover 2024
The hardest part to finding growth stocks is having an ability to understand the finer details of these companies from their valuations through to first mover advantage and having key factors on hand to make informed investment decisions.

Our experts take the guesswork out.
ASX insight Stocks Landing

Download Your Free Report

By downloading this report, you agree to our terms and conditions and privacy policy

Scroll to Top


By submitting this form, I agree to the TERMS AND CONDITIONS and PRIVATE POLICY

Income Stocks - Blogs

Please fill in your details to download the free dividend shares report.

By downloading this report, you agree to our terms and conditions and privacy policy

Just 10 Seconds Away From Your Free Report!
Income Stocks - Popup Blog

Please fill in your details to download the free dividend shares report.

By clicking 'Download Report', I accept the Privacy Policy and Member Terms & Conditions.

We will send your report instantly. Please put your correct email address and phone number.